Takeda Pharmaceutical Co Ltd
- SEC CIK
- 0001395064
- Latest filing
- Nov 13, 2025
OVID holding history
Ovid Therapeutics Inc. in every 13F filed by Takeda Pharmaceutical Co Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OVID overviewAll 13F holders of OVIDFull Q3 2025 holdings
- Shares (Q3 2025)
- 7,531,996
- Value
- $9.79M
- % of portfolio
- 59.8%
- Quarters held
- 8
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 7,531,996 | $9.79M | 59.8% | 00.0% | Unchanged | Holders |
| Q2 2025 | 7,531,996 | $2.49M | 12.7% | 00.0% | Unchanged | Holders |
| Q1 2025 | 7,531,996 | $2.35M | 14.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 7,531,996 | $7.01M | 26.4% | 00.0% | Unchanged | Holders |
| Q3 2024 | 7,531,996 | $8.89M | 23.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 7,531,996 | $5.79M | 2.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 7,531,996 | $23.0M | 7.9% | 00.0% | Unchanged | Holders |
| Q4 2023 | 7,531,996 | $24.3M | 7.4% | – | No prior filing | Holders |